TOTH A ERNEST JR, CFO of Aquestive Therapeutics ($AQST), sold shares once on the open market in the last year, totaling about $243 thousand. His most recent sale occurred on March 10, 2026. These AQST insider sales rank 8,024th among 11,678 individuals in our database, where the average is $8.6 million across roughly 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 122,003,113 | 9999.99% | 0.06% |
| March 10, 2026 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | S | Common Stock | 58254 | $4.17 | 376,112.0000 | 122,003,113 | 13.41% | 0.05% |
| March 9, 2026 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | A | Common Stock | 95000 | $0.00 | 434,366.0000 | 122,003,113 | 27.99% | 0.08% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 98,871,369 | 9999.99% | 0.06% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | A | Common Stock | 110000 | $0.00 | 358,295.0000 | 98,871,369 | 44.30% | 0.11% |
| March 7, 2025 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | F | Common Stock | 10193 | $2.65 | 348,102.0000 | 98,871,369 | 2.84% | 0.01% |
| March 9, 2025 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | Chief Financial Officer | F | Common Stock | 8736 | $2.65 | 339,366.0000 | 98,871,369 | 2.51% | 0.01% |
| March 9, 2024 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | SVP, Chief Financial Officer | F | Common Stock | 11705 | $4.88 | 248,295.0000 | 0 | 4.50% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | SVP, Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2024 | Aquestive Therapeutics, Inc. | $AQST | TOTH A ERNEST JR | SVP, Chief Financial Officer | A | Common Stock | 120000 | $0.00 | 260,000.0000 | 0 | 85.71% | 0.00% |